España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Actinium Pharma
ATNM
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.29
0.17
15.18%
At close: -
$1.25
-0.04
-3.10%
After Hours: 7:38 PM EDT
Get Report
Comment
Actinium Pharma (ATNM) Forecast
News
Earnings
Actinium Pharma (ATNM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Actinium Pharma (AMEX:ATNM) Stock
Actinium Pharma Stock (AMEX: ATNM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
Stephens & Co. Reiterates Overweight on Actin...
Benzinga Newsdesk
Monday, November 18, 2024
Actinium Pharmaceuticals Q3 EPS $(0.37) Misse...
Benzinga Newsdesk
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Friday, September 20, 2024
Actinium Pharmaceuticals Publishes Phase 3 SI...
Benzinga Newsdesk
Tuesday, August 06, 2024
5HC Wainwright & Co. Maintains Buy on Actiniu...
Benzinga Newsdesk
Actinium Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Actinium Pharmaceuticals Q2 2024 GAAP EPS $(0...
Benzinga Newsdesk
Maxim Group Maintains Buy on Actinium Pharma,...
Benzinga Newsdesk
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, August 05, 2024
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
Avi Kapoor
Dow Tumbles 950 Points; ISM Services PMI Surges In July
Avi Kapoor
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
Vandana Singh
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
Avi Kapoor
FDA Determines That Actinium Pharmaceuticals'...
Benzinga Newsdesk
Actinium shares are trading lower after the F...
Benzinga Newsdesk
Thursday, August 01, 2024
Actinium Pharmaceuticals Received U.S. Patent...
Benzinga Newsdesk
Friday, July 26, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Thursday, July 25, 2024
Actinium Pharmaceuticals Announces FDA Cleara...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Actinium Presents Data Demonstrating Actimab-...
Benzinga Newsdesk
Friday, June 14, 2024
Actinium Presents Oral Presentation Featuring...
Benzinga Newsdesk
Tuesday, June 11, 2024
Actinium Highlights Data From Completed Phase...
Benzinga Newsdesk
Monday, June 10, 2024
Actinium Highlights Mutation Data From The Ph...
Benzinga Newsdesk
Tuesday, May 21, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Wednesday, May 15, 2024
Reported Earlier, Actinium To Present Improve...
Benzinga Newsdesk
Tuesday, May 14, 2024
Stephens & Co. Initiates Coverage On Actinium...
Benzinga Newsdesk
Monday, May 13, 2024
Actinium Announces Announced Five Abstracts A...
Benzinga Newsdesk
Tuesday, May 07, 2024
Actinium Announces KOL Webinar To Highlight R...
Benzinga Newsdesk
Thursday, May 02, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Tuesday, April 30, 2024
Cantor Fitzgerald Reiterates Overweight on Ac...
Benzinga Newsdesk
Monday, April 29, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Thursday, April 18, 2024
Actinium Highlights Ability Of Iomab-B To Ove...
Benzinga Newsdesk
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ac...
Benzinga Newsdesk
Actinium Announces Iomab-B Phase 3 SIERRA Tri...
Benzinga Newsdesk
Tuesday, March 26, 2024
HC Wainwright & Co. Reiterates Buy on Actiniu...
Benzinga Newsdesk
Actinium Announces Clinical Trial to Study Io...
Benzinga Newsdesk
Tuesday, March 19, 2024
Maxim Group Maintains Buy on Actinium Pharma,...
Benzinga Newsdesk
Watching Actinium Pharmaceuticals; HC Wainwri...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Actinium...
Benzinga Newsdesk
Thursday, March 14, 2024
Actinium Pharmaceuticals Disclosed The Launch...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on Actinium...
Benzinga Newsdesk
Actinium Pharmaceuticals Has Launched A Strat...
Benzinga Newsdesk
Monday, February 26, 2024
Actinium Announces Iomab-B Markedly Increases...
Benzinga Newsdesk
Friday, February 23, 2024
Actinium Highlights Improved Survival With Io...
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, December 19, 2023
Actinium Pharmaceuticals Granted U.S. Patent #11844799: Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
Charles Gross
Monday, December 11, 2023
B. Riley Securities Maintains Buy on Actinium...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch